V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210033195 | 210027286 | 1.72 | 101.1 | Curative (C) | 2014-02-22 | 2014-07-24 | Rituximab | N | N | 210027055 | RITUXIMAB |
| 210033196 | 210010811 | 1.77 | 92.1 | Disease modification (D) | 2014-09-07 | 2015-05-20 | Rituximab | N | N | 210027083 | RITUXIMAB |
| 210033197 | 210010812 | 1.55 | 57 | Disease modification (D) | null | 2017-09-15 | Rituximab | null | null | 210027099 | RITUXIMAB |
| 210033198 | 210027288 | null | null | Disease modification (D) | null | 2015-07-08 | Rituximab (Maintenance) | N | N | 210027114 | RITUXIMAB |
| 210033199 | 210010817 | 1.59 | 63.2 | Curative (C) | 2015-07-29 | 2015-08-02 | IBRUTINIB | 2 | N | 210027124 | IBRUTINIB |
| 210033200 | 210010822 | 1.73 | 63.7 | Palliative (P) | 2017-02-05 | 2017-10-27 | IBRUTINIB | Y | N | 210027159 | IBRUTINIB |
| 210033201 | 210010824 | 1.71 | 74 | Disease modification (D) | 2017-06-09 | 2018-03-16 | IBRUTINIB | N | N | 210027183 | IBRUTINIB |
| 210033202 | 210010830 | 1.9 | 62 | Palliative (P) | 2018-07-26 | 2018-07-26 | Lomustine | N | 2 | 210027205 | LOMUSTINE |
| 210033203 | 210010847 | 1.7 | 50.6 | Palliative (P) | 2017-07-25 | 2018-03-12 | IBRUTINIB | N | N | 210027322 | IBRUTINIB |
| 210033204 | 210010851 | 1.57 | null | null | null | 2014-10-31 | Rituximab | N | N | 210027335 | RITUXIMAB |
| 210033205 | 210010861 | 0 | 60 | Curative (C) | 2018-03-01 | 2019-02-01 | IBRUTINIB | 02 | N | 210027440 | IBRUTINIB |
| 210033206 | 210010862 | 1.76 | 76 | Palliative (P) | 2013-10-06 | 2014-04-30 | IBRUTINIB | N | N | 210027442 | IBRUTINIB |
| 210033207 | 210010865 | null | null | Adjuvant (A) | 2019-05-05 | 2019-08-12 | Rituximab | N | N | 210027506 | RITUXIMAB |
| 210033208 | 210010873 | null | null | null | null | 2016-11-13 | Lomustine | N | N | 210027529 | LOMUSTINE |
| 210033209 | 210010887 | null | 70.2 | Disease modification (D) | 2013-08-04 | 2013-08-04 | IBRUTINIB | N | N | 210027612 | IBRUTINIB |
| 210033210 | 210010890 | 1.74 | null | Palliative (P) | 2017-04-30 | 2017-04-30 | IBRUTINIB | N | Y | 210027613 | IBRUTINIB |
| 210033211 | 210036089 | 1.71 | 76 | Palliative (P) | null | 2017-11-05 | Lomustine | N | N | 210027614 | LOMUSTINE |
| 210033212 | 210038520 | 1.6 | null | Palliative (P) | 2013-04-24 | 2014-01-26 | Lomustine | 02 | null | 210027631 | LOMUSTINE |
| 210033213 | 210010893 | 1.69 | 69 | Disease modification (D) | 2017-03-05 | 2017-03-05 | Lomustine | N | N | 210027662 | LOMUSTINE |
| 210033214 | 210010897 | 1.74 | 57 | Curative (C) | 2017-07-29 | 2017-07-29 | Lomustine | N | N | 210027684 | LOMUSTINE |
| 210033215 | 210010899 | null | 0 | Palliative (P) | null | 2018-10-18 | Lomustine | 02 | N | 210027688 | LOMUSTINE |
| 210033216 | 210010903 | 1.59 | 60.7 | Disease modification (D) | 2014-02-25 | 2014-02-25 | Rituximab | N | N | 210027725 | RITUXIMAB |
| 210033217 | 210010905 | null | 79.4 | Curative (C) | 2015-07-29 | 2015-07-29 | Lomustine | N | N | 210027736 | LOMUSTINE |
| 210033218 | 210021090 | null | 52.7 | Palliative (P) | 2017-12-19 | 2017-12-19 | Lomustine | 02 | N | 210027745 | LOMUSTINE |
| 210033219 | 210010912 | 1.7 | 64.6 | null | 2014-01-07 | 2014-01-07 | IBRUTINIB | N | N | 210027768 | IBRUTINIB |
| 210033220 | 210010915 | 1.85 | 82.6 | Palliative (P) | 2018-09-04 | 2018-09-29 | IBRUTINIB | N | N | 210027794 | IBRUTINIB |
| 210033221 | 210010919 | 1.7 | 80 | Curative (C) | 2016-01-07 | 2016-09-21 | VINCRISTINE | N | null | 210027812 | VINCRISTINE |
| 210033222 | 210010922 | 1.75 | 77.8 | Palliative (P) | 2014-01-18 | 2014-09-05 | FLAIR Trial | 01 | N | 210027813 | FLAIR TRIAL |
| 210033223 | 210034987 | null | 82.5 | Curative (C) | 2013-11-28 | 2013-11-29 | Bendamustine+Rituximab(Sub Courses) | N | N | 210027828 | BENDAMUSTINE + RITUXIMAB |
| 210033224 | 210010926 | null | 96 | Curative (C) | 2015-06-29 | 2015-09-10 | FLAIR Trial | Y | N | 210027835 | FLAIR TRIAL |
| 210033225 | 210010931 | 1.63 | 63.5 | Curative (C) | 2014-08-26 | 2014-10-22 | VINCRISTINE | N | N | 210027853 | VINCRISTINE |
| 210033227 | 210010945 | 1.25 | 60.3 | Curative (C) | 2015-04-09 | 2015-04-13 | BENDAMUSTINE + RITUXIMAB | 02 | N | 210027888 | BENDAMUSTINE + RITUXIMAB |
| 210033228 | 210010947 | 1.75 | 90 | Curative (C) | 2015-03-03 | 2015-04-20 | Vincristine (weekly) | N | N | 210027892 | VINCRISTINE |
| 210033229 | 210034989 | null | 93 | Curative (C) | null | 2017-10-31 | Bendamustine+Rituximab(Sub Courses) | N | null | 210027928 | BENDAMUSTINE + RITUXIMAB |
| 210033230 | 210010962 | 1.7 | 91.1 | Unknown (U) | null | 2017-08-07 | FLAIR Trial | N | Y | 210027951 | FLAIR TRIAL |
| 210033231 | 210010965 | 1.8 | 80 | Curative (C) | 2015-08-28 | 2016-04-07 | Vincristine (weekly) | 02 | N | 210027956 | VINCRISTINE |
| 210033232 | 210010966 | 1.85 | null | Curative (C) | 2014-04-13 | 2014-04-13 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 2 | N | 210027956 | FCR |
| 210033233 | 210027325 | null | null | Palliative (P) | 2017-06-01 | 2017-06-01 | Vincristine (weekly) | 02 | null | 210028008 | VINCRISTINE |
| 210033235 | 210010991 | null | 65.1 | Palliative (P) | 2018-07-13 | 2019-01-28 | BENDAMUSTINE + RITUXIMAB | N | N | 210028030 | BENDAMUSTINE + RITUXIMAB |
| 210033236 | 210010994 | 1.74 | null | Disease modification (D) | 2015-05-16 | 2015-05-20 | FLAIR Trial | N | N | 210028034 | FLAIR TRIAL |
| 210033237 | 210011001 | 1.79 | 89.3 | Palliative (P) | 2013-08-25 | 2013-11-03 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 210028049 | BENDAMUSTINE + RITUXIMAB |
| 210033238 | 210011002 | null | 72.8 | Palliative (P) | 2015-11-25 | 2015-12-05 | Bendamustine+Rituximab(Sub Courses) | 2 | N | 210028050 | BENDAMUSTINE + RITUXIMAB |
| 210033239 | 210011004 | 1.79 | 137.6 | Palliative (P) | 2012-12-29 | 2013-08-01 | FLAIR Trial | N | N | 210028065 | FLAIR TRIAL |
| 210033240 | 210011010 | 0 | 97.8 | Adjuvant (A) | 2016-10-10 | 2016-12-11 | BENDAMUSTINE + RITUXIMAB | N | N | 210028083 | BENDAMUSTINE + RITUXIMAB |
| 210033241 | 210011016 | 1.52 | 63 | Curative (C) | 2017-04-19 | 2017-10-25 | BENDAMUSTINE + RITUXIMAB | 02 | N | 210028113 | BENDAMUSTINE + RITUXIMAB |
| 210033242 | 210011019 | 1.82 | null | Adjuvant (A) | 2018-03-22 | 2018-03-29 | FCR Oral - Cycle 2 onwards | 2 | N | 210028123 | FCR |
| 210033243 | 210011022 | 1.01 | 51.7 | Palliative (P) | null | 2018-08-07 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 210028127 | FCR |
| 210033244 | 210021146 | 1.74 | 26.02 | Neo-adjuvant (N) | 2015-07-22 | 2015-07-22 | BENDAMUSTINE + RITUXIMAB | N | N | 210028143 | BENDAMUSTINE + RITUXIMAB |
| 210033245 | 210011030 | 1.78 | 82 | Palliative (P) | 2015-04-01 | 2015-05-07 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 2 | N | 210028149 | FCR |
| 210033246 | 210011030 | 1.75 | 75 | Curative (C) | 2017-03-19 | 2018-05-16 | FCR Oral - Cycle 2 onwards | N | N | 210028149 | FCR |